World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
80
Citations
24556
World Ranking
1619
National Ranking
63

Overview

Bart C. Jacobs is affiliated with Erasmus University Rotterdam in the Netherlands and has a research focus predominantly in the field of Medicine, with a specialization in Neurology.

The scientist's research spans several subfields, including:

  • Neurology
  • Cellular and Molecular Neuroscience
  • Radiology, Nuclear Medicine and Imaging
  • Immunology
  • Pathology and Forensic Medicine

The main topics addressed in their work are diverse and related primarily to neurological disorders and immune responses, including:

  • Peripheral Neuropathies and Disorders
  • Hereditary Neurological Disorders
  • Long-Term Effects of COVID-19
  • Monoclonal and Polyclonal Antibodies Research
  • Peripheral Nerve Disorders
  • Myasthenia Gravis and Thymoma
  • Nerve injury and regeneration

Jacobs has contributed multiple articles to recognized scientific journals with frequent publications in these venues:

  • Neurology
  • Journal of the Peripheral Nervous System
  • Journal of Neurology Neurosurgery & Psychiatry
  • European Journal of Neurology
  • European Journal of Paediatric Neurology

Notable recent papers authored or co-authored by Jacobs include:

  • "Intensive care unit acquired muscle weakness in COVID-19 patients" (2020) published in Intensive Care Medicine
  • "European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome" (2023) published in European Journal of Neurology
  • "Tight Blood-Glucose Control without Early Parenteral Nutrition in the ICU" (2023) published in New England Journal of Medicine
  • "COVID-19 vaccine and Guillain-Barré syndrome: let's not leap to associations" (2020) published in Brain
  • "Guillain-Barré syndrome: expanding the concept of molecular mimicry" (2022) published in Trends in Immunology

Bart C. Jacobs has collaborated frequently with a range of co-authors, including:

  • Pieter A. van Doorn
  • Sonja E. Leonhard
  • Luís Querol
  • Ruth Huizinga
  • Hugh J. Willison

Best Publications

  • Guillain-Barré syndrome.

    Hugh J Willison;Bart C Jacobs;Pieter A van Doorn

  • Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosis

    Bianca van den Berg;Christa Walgaard;Judith Drenthen;Christiaan Fokke

  • The spectrum of antecedent infections in Guillain-Barré syndrome: A case-control study

    B. C. Jacobs;P. H. Rothbarth;F.G.A. van der Meché;P. Herbrink

  • Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome.

    Pieter A van Doorn;Liselotte Ruts;Bart C Jacobs

  • The Guillain–Barré syndrome: a true case of molecular mimicry

    C. Wim Ang;Bart C. Jacobs;Jon D. Laman

  • Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome.

    Bart C. Jacobs;Pieter A. van Doorn;Anne P. Tio-Gillen;Leo H. Visser

  • Guillain-Barré syndrome associated with preceding hepatitis E virus infection.

    Bianca van den Berg;Annemiek A. van der Eijk;Suzan D. Pas;Jeremy G. Hunter

  • Cytomegalovirus infection and Guillain-Barre syndrome: The clinical, electrophysiologic, and prognostic features

    L. H. Visser;F. G. A. Van Der Meche;J. Meulstee;P. P. Rothbarth

  • Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model.

    Susan K. Halstead;Femke M. P. Zitman;Peter D. Humphreys;Kay Greenshields

  • The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barré syndrome

    Peggy C.R. Godschalk;Astrid P. Heikema;Michel Gilbert;Tomoko Komagamine

  • Hepatitis E virus and neurological injury

    Harry R. Dalton;Harry R. Dalton;Nassim Kamar;Jeroen J. J. van Eijk;Brendan N. Mclean

  • Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barré syndrome

    Krista Kuitwaard;Jenny de Gelder;Anne P. Tio-Gillen;Wim C. J. Hop

  • Hepatitis E virus: Infection beyond the liver?

    Sven Pischke;Johannes Hartl;Suzan D. Pas;Ansgar W. Lohse

  • Axonal variant of Guillain-Barré syndrome associated with Campylobacter infection in Bangladesh

    Z. Islam;B. C. Jacobs;A. van Belkum;Q. D. Mohammad

  • Miller Fisher anti-GQ1b antibodies: alpha-latrotoxin-like effects on motor end plates.

    J. J. Plomp;P. C. Molenaar;G. M. O'hanlon;B. C. Jacobs

  • Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy.

    Carina Bunschoten;Bart C Jacobs;Peter Y K Van den Bergh;David R Cornblath

  • Neuralgic amyotrophy and hepatitis E virus infection

    Jeroen J.J. van Eijk;Richie G. Madden;Annemiek A. van der Eijk;Jeremy G. Hunter

  • Serum anti‐GQ1b IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller Fisher syndrome

    B. C. Jacobs;H. P. Endtz;F. G. A. Van Der Meche;M. P. Hazenberg

  • A novel link between Campylobacter jejuni bacteriophage defence, virulence and Guillain–Barré syndrome

    R. Louwen;D. Horst-Kreft;A. G. de Boer;L. van der Graaf

  • Incidence and Prevalence of Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Systematic Review and Meta-Analysis

    Merel C Broers;Carina Bunschoten;Daan Nieboer;Hester F Lingsma

  • Structure of Campylobacter jejuni Lipopolysaccharides Determines Antiganglioside Specificity and Clinical Features of Guillain-Barré and Miller Fisher Patients

    C. W. Ang;J. D. Laman;H. J. Willison;E. R. Wagner

Frequent Co-Authors

Hubert P. Endtz
Hubert P. Endtz Erasmus University Rotterdam
Hugh J. Willison
Hugh J. Willison University of Glasgow
P.A. van Doorn
P.A. van Doorn Erasmus University Rotterdam
Alex van Belkum
Alex van Belkum BaseClear B.V.
Hester F. Lingsma
Hester F. Lingsma Erasmus University Rotterdam
Michel Gilbert
Michel Gilbert National Academies of Sciences, Engineering, and Medicine
Jon D. Laman
Jon D. Laman University Medical Center Groningen
Jaap A. Wagenaar
Jaap A. Wagenaar Utrecht University
David R. Cornblath
David R. Cornblath Johns Hopkins University School of Medicine
Jaap J. Plomp
Jaap J. Plomp Leiden University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring complementary healthcare degrees can broaden career opportunities. Many professionals transition into nursing roles, where understanding the immune system is crucial. If you're new to nursing, consider online adn programs for non nurses that offer accessible pathways into nursing without prior experience.

For accelerated options, especially if you already hold a degree, the 12-month accelerated nursing programs provide fast-tracked education designed to meet workforce demand without sacrificing quality.

Entry-level roles like Licensed Practical Nurse (LPN) offer a quicker route into healthcare, with many options available among easy lpn programs to get into. These programs prepare graduates for hands-on patient care roles that often collaborate with immunology specialists.

For advanced practice, particularly in clinical settings related to immunological health, exploring nurse practitioner programs with easy admission can be a strategic choice. These programs emphasize critical thinking and advanced medical knowledge, including immunological conditions.

Best Scientists Citing Bart C. Jacobs

Trending Scientists

Recently Published Articles